Twi Biotechnology (6610)

Currency in TWD
52.20
-0.20(-0.38%)
Closed·
Advertisement
Trading near 52-week High
6610 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
51.0057.20
52 wk Range
12.8557.20
Key Statistics
Bid/Ask
18.55 / 18.79
Prev. Close
12.95
Open
52.5
Day's Range
51-57.2
52 wk Range
12.85-57.2
Volume
3.95M
Average Volume (3m)
1.11M
1-Year Change
59.1463%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
6610 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Stock generally trades with high price volatility

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

Earnings

Latest Release
10/08/2026
EPS / Forecast
-0.45 / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

Compare 6610 to Peers and Sector

Metrics to compare
6610
Peers
Sector
Relationship
P/E Ratio
−36.0x−6.5x−0.3x
PEG Ratio
4.960.170.00
Price/Book
22.6x1.9x2.6x
Price / LTM Sales
-87.1x3.0x
Upside (Analyst Target)
-529.4%58.2%
Fair Value Upside
Unlock10.5%7.5%Unlock

TWi Biotechnology, Inc., a clinical-stage biopharmaceutical company, develops and sells drugs for innate immunity-related diseases in Taiwan. The company development pipeline comprises AC-203, which is in Phase 2 clinical trial for various indications, including epidermolysis bullosa simplex, epidermolysis bullosa, arthritis, gout, and diabetes mellitus; AC- 1101, which is in Phase Ib trial for the treatment of vitiligo and preclinical stage for the treatment of atopic dermatitis, as well as granuloma annulare and rare autoimmune skin diseases; and NORA520, an oral prodrug, which is hydrolyzed to Brexanolone. It has a drug development agreement with Hong Kong Winhealth Pharma Group Co., Limited. in Mainland China, Hong Kong, and Macao markets. TWi Biotechnology, Inc. was founded in 2010 and is based in Taipei, Taiwan. TWi Biotechnology, Inc. operates as a subsidiary of Xinchen Investment Company.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
0.000.00%0.00
Other Institutional Investors
169.59M82.50%8.47B
Public Companies & Retail Investors
35.99M17.50%1.80B
Total
205.58M100.00%10.27B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Xinchen Investment Co., Ltd.78.68%161,758,3478,079,829
Fubon Financial Holding Venture Capital Co., Ltd.0.83%1,706,00085,215

FAQ

What Is the Twi BioTech (TPEX: 6610) Share Price Today?

The Twi BioTech stock price today is 52.20 TWD.

What Stock Exchange Does Twi BioTech (6610) Trade On?

Twi BioTech is listed and trades on the Taipei Exchange.

What Is the Ticker (Stock Symbol) for Twi BioTech?

The stock symbol (also called a 'ticker') for Twi BioTech is "6610."

What Is the Current Twi BioTech Market Capitalisation?

As of today, Twi BioTech (TPEX: 6610) market cap is 5.59B TWD.

What Is Twi BioTech's (6610) Earnings Per Share (TTM)?

The Twi BioTech EPS is currently -2.22 (Trailing Twelve Months).

Is 6610 a Buy or Sell From a Technical Analyst Perspective?

Based on today's Twi BioTech moving averages and other technical indicators, the daily buy/sell signal for 6610 stock is Strong Buy.

How Many Times Has Twi BioTech Stock Split?

Twi BioTech has split 1 times. (See the 6610 stock split history page for full effective split date and price information.)

What is the current trading status of Twi BioTech (TPEX: 6610)?

As of 07/10/2026, Twi BioTech (6610) is trading at a share price of 52.20 TWD, with a previous close of 12.95 TWD. The stock has fluctuated within a day range of 51.00 TWD to 57.20 TWD, while its 52-week range spans from 12.85 TWD to 57.20 TWD.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.